MAKING CLOUD WORK IS MAKING INTELLIGENT DECISIONS ON THE GO
Cloud is now hygiene. Axtria DataMAx™ enables Data Governance and Vendor Management To Ensure Consumers Have The Right Insights They Need Anywhere, Anytime
Enabling Faster Go-To-Market With High Performance Data Management
Cloud Migration With Axtria DataMAxTM
Simplified Access To Multiple Applications Delivered “As A Service” With Security And End-To-End SLAs
Close alignment of
cloud migration with
business needs and goals
Active coordination
across different verticals
and subsidiaries
Actionable and
phased migration from
On premise to the cloud
Informed partnership
with leading cloud
providers
Axtria DataMAxTM Accelerators
In-Built Accelerators For Successful Cloud Migration
Data Ingestion, Tracking & Monitoring Framework
- Fast data onboarding and tracking
- Pre-built library of data catalogs and quality checks
- Automatic scheduler for data ingestion
- Real-time dashboards
Data Quality Management Framework
- Applied end-to-end from source files to analytics layer
- File level checks
- Audit balance and control
- tatistical process control
- Audit variation exception report
Pre-Built Pharma Commercial Data Model
- Pharma commercial ready data model, business logic, data quality management rules
Data Governance Framework
- Availability, quality, integrity and security of the data assets
- Industry best practices and benchmarks
Key Benefits
Cloud Migration With Axtria DataMAxTM
50
Cost reduction and lower dependency on consultants
99.9
Improvement in data quality across all layers
35
Improvement in data ingestion and data processing cycle time
60
Reduction in data management issues
40
Increase in efficiency of operations
Unstructured Data
Data Sources
(MDM)
Lakes (Big Data)
Machine Learning
Smart Reporting
Unstructured Data
Data Sources
(MDM)
Lakes (Big Data)
Machine Learning
Smart Reporting
Customer Success Stories
Explore How Axtria Helps Life Sciences Businesses Achieve Commercial Success.
Commercial Data Environment And Self-Service Analytics Enabled By Axtria DataMAx™
New drug development, especially vaccines, is considered high-risk and expensive. As per a recent report, the cost of developing a vaccine is estimated to be between $200 million a ...
Automated Email Campaigns Support The Patient Assistance Journey For Enhanced Treatment Outcomes
Diagnosis of a rare disease, lack of therapies, and small patient populations all lead to significant challenges in rare disease management and support of these patients. ...
Orphan Drug Commercialization For An SMB Pharma Organization Enabled By Axtria DataMAx™
The orphan drug market is predicted to generate $217 billion by 2024, i.e., 18% of the overall prescription sales. The orphan drug market is historically dominated by the big pharm ...
